Whittier Trust CO Of Nevada Inc Hutchmed (China) LTD Transaction History

Whittier Trust CO Of Nevada Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$8.59 - $20.77 $455 - $1,100	-53 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$35.66 - $42.94 $641 - $772	18 Added 51.43%	53 $2,000
Q2 2021 Jul 29, 2021	BUY	$23.7 - $39.27 $284 - $471	12 Added 52.17%	35 $1,000
Q3 2020 Oct 30, 2020	BUY	$25.8 - $34.61 $206 - $276	8 Added 53.33%	23 $1,000
Q4 2018 Feb 07, 2019	BUY	$23.09 - $37.69 $346 - $565	15 New	15 $0

8.25M

3.8K

2.4K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.29B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.